'Game changing' success for Biomaster in SARS-CoV-2 virus testing

20
Nov

We are pleased to announce that after extensive testing we can confirm that Biomaster is active on both porous and non-porous substrates against SARS-CoV-2.

SARS-CoV-2 is the virus that causes Covid-19 and is a member of the Coronavirus family of viruses.

Until very recently, only Government laboratories were licenced to handle the SARS-CoV-2 virus, due to the virility and danger of the strain. But now selected Class 3 laboratories around the world are able to test products to the viral ISO standard.

ISO 21702 is the test for non-porous surfaces

ISO 18184 is the test for porous surfaces.

Porous substrate with Biomaster showed a 68% reduction of SARS-CoV-2

in 15 minutes and >99% in 4 hours.*

Non-porous substrate with Biomaster showed a 60% reduction of SARS-CoV-2

in 2 hours and >99% in 24 hours.*

(Results are based on comparison to controls with no Biomaster)

"We are very excited to be sharing these game-changing results with our Biomaster partners, as they have been extremely patient in waiting for the availability of SARS-CoV-2 testing," comments Addmaster Founder & CEO Paul Morris.

"Having the data to prove the technology is effective against SARS-CoV-2 on both substrate types is a huge step change for the industry and it will now allow the technology to be rolled out quickly across all markets.

We will be shortly commencing rapid testing of our customers products to the same ISO standards and expect to see major announcements coming soon from our Biomaster partners."

*Results show efficacy of Biomaster protected products only. It does not guarantee protection to the user or others against viruses.


Back to articles